Anti-Human CD30 Ligand (Clone 116614)

Quality Tested by Leinco Flow Cytometry: It is recommended to use the indirect method for signal enhancement when enumerating cells expressing CD30 Ligand. A suggested method would be to stain cells expressing CD30 Ligand with 0.25 µg per 1-2.5 x 10⁶ cells in a total staining volume of ≤200 µl followed by PN:M1189.

CD30 Ligand

Next Day Ambient

The CD30 ligand is a type II transmembrane glycoprotein of the tumor necrosis factor ligand superfamily. CD30L is expressed on the cell surface of activated T cells, B cells, and monocytes. Recombinant CD30L has been shown to co-stimulate T cells and to act as a mitogen for Hodgkin's disease derived cell lines. The receptor for CD30L, CD30/ TNFRSF8/CD153, is a type I cytokine receptor that is highly expressed by activated T cells, Hodgkin and Reed- Sternberg (H-RS) cells, and anaplastic large cell lymphoma cells. CD30 ligation by CD30L mediates pleiotropic effects including cell proliferation, activation, differentiation and cell death by apoptosis.

Neutralization: This antibody is useful for neutralization of Human CD30 Ligand bioactivity. The antibody dose required to neutralize 50% (ND₅₀) of the biological activity of Human CD30 Ligand (at 1.0 ng/ml) is 1.0-4.0 µg/ml.

Mouse Anti-Human CD30 Ligand (Clone 116614) recognizes an epitope on Human CD30 Ligand. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. This antibody showed no cross-reactivity with rhCD27 Ligand, rmCD30 Ligand or rhCD40 Ligand.

This monoclonal antibody has been 0.2 µm filtered and lyophilized from modified Dulbecco's phosphate buffered saline (1X PBS) pH 7.2 - 7.4 containing 5.0% w/v trehalose with no calcium, magnesium or preservatives present.

Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.